Marie-Odile Krebs focuses on Schizophrenia, Genetics, Psychosis, Psychiatry and Internal medicine. His biological study deals with issues like Proband, which deal with fields such as Genetic association, Heritability and Phenotypic trait. Marie-Odile Krebs works mostly in the field of Genetics, limiting it down to topics relating to Autism and, in certain cases, Intellectual disability, Transmission disequilibrium test, Bioinformatics and Phenotype, as a part of the same area of interest.
His research integrates issues of Young adult, Glutamate receptor, Psychosocial, Minor physical anomalies and Genetic determinism in his study of Psychosis. His research on Psychiatry frequently connects to adjacent areas such as Clinical psychology. The various areas that he examines in his Internal medicine study include Endocrinology, Neuroscience and Cardiology.
Marie-Odile Krebs mainly focuses on Schizophrenia, Psychosis, Psychiatry, Clinical psychology and Neuroscience. His study in Schizophrenia is interdisciplinary in nature, drawing from both Genetics, Autism, Disease and Audiology. His Psychosis research includes elements of Young adult, Internal medicine, Psychopathology, Cognition and Motor coordination.
His research in Internal medicine intersects with topics in Endocrinology and Oncology. His work in the fields of Schizophrenia, Substance abuse, Neurological soft signs and Cannabis overlaps with other areas such as In patient. Many of his studies involve connections with topics such as Endocannabinoid system and Neuroscience.
Marie-Odile Krebs spends much of his time researching Psychosis, Schizophrenia, Clinical psychology, Psychiatry and Cognition. His studies in Psychosis integrate themes in fields like Psychological intervention, Cohort, DNA methylation, Social cognition and Depression. He combines subjects such as Transcranial magnetic stimulation, Internal medicine and Audiology with his study of Schizophrenia.
His Clinical psychology study integrates concerns from other disciplines, such as Logistic regression, Young adult, Case-control study, Anxiety and Wisconsin Card Sorting Test. His work on Schizophrenia, Intervention, Cannabis Dependence and Early intervention in psychosis as part of general Psychiatry research is frequently linked to In patient, thereby connecting diverse disciplines of science. His biological study spans a wide range of topics, including Developmental psychology and Ultra high risk.
Marie-Odile Krebs mainly investigates Psychosis, Schizophrenia, Psychiatry, Clinical psychology and At risk mental state. His Psychosis research is multidisciplinary, relying on both DNA methylation, Young adult, Autism, Social cognition and Cohort. The concepts of his Schizophrenia study are interwoven with issues in Transcranial magnetic stimulation, Quality of life and Rating scale.
As part of the same scientific family, Marie-Odile Krebs usually focuses on Psychiatry, concentrating on Early detection and intersecting with Prodromal phase, Ultra high risk and Neuropsychology. In Clinical psychology, Marie-Odile Krebs works on issues like Case-control study, which are connected to Hydrocortisone, Cohort study, Basal and Global Assessment of Functioning. His At risk mental state research is multidisciplinary, incorporating perspectives in Audiology, Disease and Eye movement.
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.
Luc Mallet;Mircea Polosan;Nematollah Jaafari;Nicolas Baup.
The New England Journal of Medicine (2008)
Clinical spectrum of CADASIL: a study of 7 families
H Chabriat;K Vahedi;M.G Bousser;M.T Iba-Zizen.
The Lancet (1995)
Increased exonic de novo mutation rate in individuals with schizophrenia
Simon L Girard;Julie Gauthier;Anne Noreau;Lan Xiong.
Nature Genetics (2011)
Altering the course of schizophrenia: progress and perspectives
Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead.
Nature Reviews Drug Discovery (2016)
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Julie Gauthier;Nathalie Champagne;Ronald G. Lafrenière;Lan Xiong.
Proceedings of the National Academy of Sciences of the United States of America (2010)
Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals.
M. O. Krebs;J. M. Desce;M. L. Kemel;C. Gauchy.
Journal of Neurochemistry (1991)
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation.
Fadi F. Hamdan;Julie Gauthier;Dan Spiegelman;Anne Noreau.
The New England Journal of Medicine (2009)
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
Piton A;Gauthier J;Hamdan Ff;Lafrenière Rg.
Molecular Psychiatry (2011)
Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations
Jim van Os;Jim van Os;Bart P. Rutten;Inez Myin-Germeys;Philippe Delespaul.
Schizophrenia Bulletin (2014)
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia
Julie Gauthier;Tabrez J. Siddiqui;Peng Huashan;Daisaku Yokomaku.
Human Genetics (2011)
If you think any of the details on this page are incorrect, let us know.